Photo via Washington Examiner

White House withdraws Heidi Overton’s nomination to become next FDA commissioner

Read the original at Washington Examiner ↗
Cite

Lim, N. (2026, November 18). White House withdraws Heidi Overton’s nomination to become next FDA commissioner. Washington Examiner. https://www.washingtonexaminer.com/news/white-house/4806936/white-house-heidi-overton-nomination-fda-commissioner/

Dated from the outlet's own feed. Check the original for its byline.

Washington Examiner · collected 2026-11-18 · by Naomi Lim

Quick Summary

The White House has withdrawn Heidi Overton’s nomination to become the next FDA commissioner, just before the Senate Health, Education, Labor and Pensions Committee was scheduled to review her nomination on Wednesday. A White House official confirmed the withdrawal to the Washington Examiner on Tuesday.
Written by AI on 2026-11-18, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

How they differ

11 outlets covered “White House withdraws Heidi Overton’s nomination to become”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

Washington ExaminerThis outlet18 Nov

The White House has withdrawn Heidi Overton’s nomination to become the next FDA commissioner, just before the Senate Health, Education, Labor and Pensions Committee was scheduled to review her nomination on Wednesday. A White House official confirmed the withdrawal to the Washington Examiner on Tuesday.

White House withdraws Heidi Overton’s nomination to become next FDA commissioner (this article)
CBS News18 Nov

The White House has withdrawn Dr. Heidi Overton's nomination as the new FDA commissioner, a position she was selected for by President Trump. The Senate health committee was set to vote on her nomination on Wednesday, but the White House has since decided to remove her from consideration. Axios was the first to report this change.

White House drops Heidi Overton's nomination for FDA commissioner →2 articles from CBS News on this story
New York Post18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) due to insufficient support from Senate lawmakers. Overton, a physician and deputy director of the White House Domestic Policy Council, faced significant opposition for her alleged ties to the tobacco industry, pro-vaping stance, and anti-abortion views. Critics demonstrated their disapproval by placing signs…

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback →
The Straits Times18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA) before her confirmation hearing, according to Axios. The decision was made due to a lack of congressional support, especially after criticism from a former Health Secretary’s adviser and opposition from several Republican senators. This move adds to the FDA’s ongoing leadership challenges, with the agency…

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says →
Toronto Star18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration due to insufficient Senate Republican support. Overton, a Trump-aligned physician and White House domestic policy adviser, was nominated in August to replace Dr. Marty Makary, who had a controversial tenure. Her nomination was intended to stabilize the FDA with a Trump loyalist, but faced opposition that prevented…

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans →
NBC News18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to become the FDA commissioner due to Republican senators' concerns about her lack of managerial experience. The decision came shortly before Overton’s scheduled Senate Health Committee vote, where she needed at least one Republican vote to advance. Senators Cassidy, Collins, and Murkowski expressed reservations about Overton’s qualifications and her…

White House drops Heidi Overton’s FDA nomination →
Show 5 more outlets
ABC News (US)18 Nov

Dr. Heidi Overton's nomination to become the FDA commissioner was withdrawn on Tuesday after facing significant opposition from some Republican senators. The nomination encountered hurdles primarily due to Overton’s positions on abortion, vaccines, and vaping, according to sources familiar with the situation.

Trump's pick Heidi Overton dropped as nominee for FDA commissioner →
Just the News18 Nov

The White House has withdrawn Heidi Overton's nomination to lead the Food and Drug Administration (FDA) just one day before her scheduled vote by the Senate Health, Education, Labor and Pensions Committee. Overton, a physician and deputy director of the White House Domestic Policy Council, faced skepticism from some Republicans about her involvement in changing childhood vaccine recommendations. A senior…

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report →
The Guardian18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration after bipartisan concerns about her willingness to challenge President Trump’s policies, particularly regarding vaccines and abortion. Republican senator Bill Cassidy, who chairs the Senate health committee, had expressed reservations about her support for Trump’s vaccine plans and her stance on abortion rights…

White House withdraws nomination of Heidi Overton to lead FDA →
Daily Caller18 Nov

The Trump administration withdrew Heidi Overton’s nomination to lead the FDA on November 18, 2026, due to lack of support in the Senate. Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated in August and faced opposition from Democrats, some Republicans, and MAHA activists. The White House cited the need for a more populist approach to health as the reason for the…

MAHA Rejoices After White House Drops Controversial FDA Nomination →

Where they agree and split

Framing

How the first headlines put it

Attributed to a source2
Stated as fact8
The headlines (10)

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says The Straits Times · attributed to a source

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report Just the News · attributed to a source

Trump FDA nominee Heidi Overton struggling to win GOP support CBS News · stated as fact

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback New York Post · stated as fact

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans Toronto Star · stated as fact

White House drops Heidi Overton’s FDA nomination NBC News · stated as fact

White House pulls Trump’s FDA pick Heidi Overton on eve of Senate panel vote Fox News · stated as fact

Trump's pick Heidi Overton dropped as nominee for FDA commissioner ABC News · stated as fact

White House withdraws nomination of Heidi Overton to lead FDA The Guardian · stated as fact

White House withdraws Heidi Overton’s nomination to become next FDA commissioner Washington Examiner · stated as fact

The full story: what happened, how it changed, and all 12 articles →

Compared with similar articles

This article reads unscored and hedges 0% of its claims. Each row says how that neighbour differs.
The Straits Times
Hedges 3 of 17 claims Outlet record 64/100
CBS News
Hedges 1 of 4 claims Outlet record 67/100
New York Post
Leans left Hedges 0 of 7 claims Outlet record 66/100
NBC News
Leans right Hedges 1 of 19 claims Outlet record 78/100
The Guardian
Leans right Hedges 1 of 18 claims Outlet record 64/100
ABC News (US)
Leans right Hedges 0 of 4 claims Outlet record 67/100
Toronto Star
Leans right Hedges 0 of 3 claims Outlet record 64/100

Story

White House withdraws Heidi Overton’s nomination to become
Other · 12 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
2
sentences that state something as happening or true
Uncertain
0%
0 of 2 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
67/100
Washington Examiner's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
12
Other
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-18 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Washington Examiner · 5091 article(s) · 11 correction(s) detected
Running correction rate · 11 correction(s)

Who wrote this

Naomi Lim
91 article(s) here · 0 carrying a prediction
“I would not mind that,” Trump told reporters on Monday as he departed for a four-day Asia trip.
The prospect of another impeachment attempt could bode well for Secretary of War Pete Hegseth‘s political future, should he decide to run for president.
President Donald Trump will not discuss the alleged Chinese spy scandal that precipitated the downfall of former Nvidia CEO Jensen Huang with Chinese President Xi Jinping when he meets with him twice during his trip next week to Asia.
EXCLUSIVE — Poorly articulated healthcare positions may have cost Republicans critical Senate races after Democrats used their policy stances against them in the 2026 midterm elections, new research shows.
“I am not running in 2028, but I will continue to talk about the things that I care about,” Haley told CNBC on Wednesday.
2026-11-11 · assertive framing · Nikki Haley rules out 2028 White House bid
President Donald Trump announced that White House deputy chief of staff for policy Stephen Miller will replace Susie Wiles as his chief of staff.
Democrats recapturing control of both the House and Senate, in addition to reclaiming a number of governors’ mansions, has given the party the opportunity to demonstrate its mettle before what is expected to be a fiercely fought presidential primary for the 2028 nomination.
“The headwinds against the Republicans may be so strong that that won’t matter.”
Republicans were so punch-drunk Tuesday night that they couldn’t even get off the mat to agree on who to blame for their electoral bloodbath.
Maybe we should ask the hundreds of dead civilians in Bucha what they think of Putin’s humanitarian instincts?”
2026-11-04 · assertive framing · Brian Poindexter defeats scandal-plagued Max Miller
Also by Naomi Lim
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 91 articles by Naomi Lim →

Topics

Food and Drug Administration The White House White House the Senate Health, Education, Labor and Pensions Committee the Washington Examiner

Subjects

Food and Drug Administration ORG · 1× Heidi Overton’s PERSON · 1× The White House ORG · 1× White House ORG · 1× the Senate Health, Education, Labor and Pensions Committee ORG · 1× the Washington Examiner ORG · 1×

Narrative

The White House has withdrawn Heidi Overton’s nomination to become the next Food and Drug Administration commissioner before the Senate Health, Education, Labor and Pensions Committee was due to consider her on Wednesday.
framing: assertive · carried by 1 article(s) · first seen 2026-11-18
2026-11-18 · Washington Examiner
White House withdraws Heidi Overton’s nomination to become next FDA commissioner · assertive framing

Claims (2 extracted, 0 hedged)

The White House has withdrawn Heidi Overton’s nomination to become the next Food and Drug Administration commissioner before the Senate Health, Education, Labor and Pensions Committee was due to consider her on Wednesday. asserted
Committee → withdraw → Wednesday
“Can confirm nomination pulled,” a White House official told the Washington Examiner on Tuesday. asserted
official → confirm → Tuesday
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support